Celecoxib in Treating Patients With Bladder Cancer
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This randomized phase IIb/III trial is studying celecoxib to see how well it works in
preventing disease recurrence in patients who have bladder cancer. Chemoprevention therapy is
the use of certain drugs to try to prevent the development or recurrence of cancer. The use
of celecoxib may be an effective way to prevent the recurrence of bladder cancer